Dr. David Malkin (President, FCIHR) – January 1, 2022 to December 31, 2023
September 6, 2022
CONGRATULATIONS, DR. DAVID MALKIN!
Election to the Royal Society of Canada.
Click here to read more.
Click here for Press Release
Click here for U of T Announcement
The #RSC is delighted to announce this year’s Class of 2022! #rscBRAVOsrc to the 102 new Fellows and 54 Members of the #CollegeofNewScholars. This outstanding cohort will be officially inducted at the #COEE2022 in November. We look forward to welcoming you all, congratulations! pic.twitter.com/UIGYujJ1S0
— RSC // SRC (@RSCTheAcademies) September 6, 2022
Our next Impact Series airs Feb 1 at 1 PM PT and will feature Dr. David Malkin, an expert in cancer predisposition syndrome at The Hospital for Sick Children in Toronto. Make sure to save the date! #StBaldricksImpactSeries #ChildhoodCancer https://t.co/5h62ndJLmH pic.twitter.com/2QyOkH71cE
— St. Baldrick’s Foundation (@StBaldricks) January 25, 2023
August 18, 2022 – Congratulations, Dr. Malkin!
Congratulations to @DavidMalkin1, recipient of the @cancersociety O. Harold Warwick Prize!
This award is given for outstanding achievements in cancer control research.
Read more: https://t.co/W6aOS0KZ9i pic.twitter.com/IDKxKhd21K
— Research at Canadian Cancer Society (@CCSResearch) August 18, 2022
Congrats to Drs. Michael Taylor & David Malkin on this @CCSResearch recognition! Taylor was recognized with @cancersociety Robert L. Noble Prize for his #SKResearch achievements in medulloblastoma & Malkin received the O. Harold Warwick Prize for his #CancerGenetics research. https://t.co/9UptpSeF2a
— SickKids_TheHospital (@SickKidsNews) August 18, 2022
April 4, 2022 – Congratulations, Dr. David Malkin!
AACR-St. Baldrick’s Foundation Award for Outstanding Achievement in Pediatric Cancer Research: David Malkin, MD, FRCPC (Photo)
This award recognizes an individual in any sector who has significantly contributed to any area of pediatric cancer research, resulting in the fundamental improvement of the understanding and/or treatment of pediatric cancer.
Congrats to Dr. David Malkin, recognized by @AACR for his paediatric cancer research on Li-Fraumeni Syndrome and the genetic & genomic mechanisms of #ChildhoodCancer susceptibility. He is also recognized for spearheading genomics efforts to improve cancer treatment. #SKResearch https://t.co/jk2WczfKPC
— SickKids_TheHospital (@SickKidsNews) April 5, 2022
——————————————————————————————————————–
Dr. David Malkin, clinician-scientist, cancer physician and academic leader, is appointed 2nd President of Friends of CIHR
Click here to Download Announcement
Toronto – October 15, 2021 – The Board of Directors of Friends of Canadian Institutes of Health Research (FCIHR) is pleased to announce that Dr. David Malkin, MD, FRCPC is appointed President and Board Chair of FCIHR – effective January 1, 2022. Dr. Malkin is a pediatric oncologist, an active clinician-scientist, a committed educator and an accomplished administrative leader.
Dr. Malkin is Professor of Pediatrics and Medical Biophysics in the Faculty of Medicine at the University of Toronto and is the CIBC Children’s Foundation Chair in Child Health Research, Director of the Cancer Genetics Program, and co-lead of the Precision Child Health initiative at the Hospital for Sick Children. In addition, he leads regional and national programs in precision oncology for children, adolescents and young adult cancer patients with the aim to transform the outcomes for these patients. Dr. Malkin’s research program focuses on genetic and genomic mechanisms of childhood cancer susceptibility, advances from which have led him to receive many awards and recognitions.
Dr. Malkin succeeds Dr. Aubie Angel, founding President of FCIHR, who notes:
“I am delighted with this Appointment as Dr. David Malkin brings new energy and perspective to the vision and mission of FCIHR and will provide fresh leadership and direction for the many members of our vibrant enterprise”.
FCIHR is a national not-for-profit organization that was established in 2000 to support the goals and ideals of the Canadian Institutes of Health Research (CIHR) and to communicate the value of health research to a broad, multifaceted public audience. Through a spectrum of programs, FCIHR also seeks to attract and support young health science trainees and scientists in their career development. The Henry G. Friesen International Prize in Health Research program, which began in 2006 and which includes visits and scholarly events in Canadian universities, exemplifies our mission. FCIHR also convenes public gatherings and roundtables of experts to discuss important health sciences issues of the day, and therein collaborates with like-minded Canadian health science organizations in all sectors.
For further information on Friends of CIHR and its various programs, please visit: www.fcihr.ca or contact: Cristina S. Castellvi. Tel. #: (416) 506-1597. Email: fcihr@fcihr.ca